AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2013
Mar 28, 2013
34117_dirs_2013-03-28_4ec262d5-7d78-4688-ab9c-8701caff31d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2013-03-28
Reporting Person: Williams Kent B. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-28 | Employee Stock Options (Right to Buy) | $0.195 | A | 300000 | Acquired | 2023-03-28 | Common Stock (300000) | Direct |
Footnotes
F1: On March 28, 2013, the reporting person was granted an option to purchase 300,000 shares of common stock. Options vest and become exercisable in four (4) equal installments on each March 31, 2013, June 30, 2013, September 30, 2013 and December 31, 2013.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6